Literature DB >> 16235474

Serum erythropoietin levels in septic shock.

F Tamion1, V Le Cam-Duchez, J F Menard, C Girault, A Coquerel, G Bonmarchand.   

Abstract

Erythropoietin is a glycoprotein hormone mainly released by the kidney, which stimulates red blood cell production. However, in sepsis, the mechanisms responsible for the final increase in circulating erythropoietin remain unclear Seventeen critically ill patients with Simplified Acute Physiologic Score average 66 (range 43 to 103) were included in this study. Ten patients survived and seven died within 28 days. Blood samples obtained at different times were assayed for erythropoietin, cytokine levels and lactate measurements. PCO2 gap was assessed to detect the presence of gastric mucosal acidosis. Erythropoietin decreased in the patients who survived while it remained high or increased in non-survivors (37+/-6.5 vs 147+/-6. 7 UI/l respectively, P<0.05). Erythropoietin plasma levels were correlated with IL-6 levels (r=0.84, P<0.05) and TNFalpha levels (r=0.84, P<0.05). We observed a significant positive relationship between erythropoietin plasma levels and lactate concentrations (r= 0.89, P< 0. 05) and with PCO2 gap (r=0.9, P < 0.05). No correlation was found between erythropoietin concentration and the other parameters. High serum erythropoietin levels in non-survivors were observed with septic shock despite an increase in the levels of proinflammatory cytokines. We found a relationship between erythropoietin concentration and biological markers of tissue hypoperfusion i.e. lactate levels or PCO2 gap. This relationship could suggest tissue hypoperfusion as the stimulating factor for erythropoietin production in septic shock.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16235474     DOI: 10.1177/0310057X0503300505

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  5 in total

Review 1.  Sepsis biomarkers: a review.

Authors:  Charalampos Pierrakos; Jean-Louis Vincent
Journal:  Crit Care       Date:  2010-02-09       Impact factor: 9.097

Review 2.  The Effect of Recombinant Human Erythropoietin on Bacterial Growth: A Dual-Edged Sword.

Authors:  Ankur Mittal; Vandana Singh; Sheemona Chowdhary; Amal Moideen; Deepak Kumar; Kunal Maniar; Rajasri Bhattacharyya; Dibyajyoti Banerjee
Journal:  Kidney Dis (Basel)       Date:  2018-11-13

Review 3.  Bench to bedside: A role for erythropoietin in sepsis.

Authors:  Andrew P Walden; J Duncan Young; Edward Sharples
Journal:  Crit Care       Date:  2010-08-06       Impact factor: 9.097

4.  Repurposing of High-Dose Erythropoietin as a Potential Drug Attenuates Sepsis in Preconditioning Renal Injury.

Authors:  Wiwat Chancharoenthana; Kanyarat Udompronpitak; Yolradee Manochantr; Piyawat Kantagowit; Ponthakorn Kaewkanha; Jiraporn Issara-Amphorn; Asada Leelahavanichkul
Journal:  Cells       Date:  2021-11-12       Impact factor: 6.600

Review 5.  Disruption of Kidney-Immune System Crosstalk in Sepsis with Acute Kidney Injury: Lessons Learned from Animal Models and Their Application to Human Health.

Authors:  Kaice LaFavers
Journal:  Int J Mol Sci       Date:  2022-02-01       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.